{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:14:34Z","timestamp":1793394874784,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["2352"],"award-info":[{"award-number":["2352"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115817","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:01:40Z","timestamp":1763658100000},"page":"115817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Ameliorative effects of chitosan nanoparticles containing a scorpion-derived potassium channel inhibitory peptide (alpha-KTx 3.13) in a juvenile model of rheumatoid arthritis"],"prefix":"10.1016","volume":"168","author":[{"given":"Fatemeh","family":"Kazemi-Lomedasht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Chiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorour","family":"Ramezanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayda","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2025.115817_bb0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00296-024-05591-8","article-title":"Rheumatoid arthritis epidemiology: a nationwide study in Poland","volume":"44","author":"Krajewska-W\u0142odarczyk","year":"2024","journal-title":"Rheumatol Int [Internet]."},{"issue":"3","key":"10.1016\/j.intimp.2025.115817_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/0115733971268416231116184056","article-title":"A review of the occurrence of rheumatoid arthritis and potential treatments through medicinal plants from an Indian perspective","volume":"20","author":"Shekh","year":"2024","journal-title":"Curr. Rheumatol. Rev."},{"issue":"11","key":"10.1016\/j.intimp.2025.115817_bb0015","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.amjmed.2007.04.005","article-title":"Rheumatoid arthritis: diagnosis and management","volume":"120","author":"Majithia","year":"2007","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115817_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99249","article-title":"TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17","volume":"3","author":"Cook","year":"2018","journal-title":"JCI Insight"},{"issue":"20","key":"10.1016\/j.intimp.2025.115817_bb0025","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115817_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interf. Cytokine Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115817_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s11658-024-00646-x","article-title":"Caspase-8 in inflammatory diseases: a potential therapeutic target","volume":"29","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2025.115817_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajpath.2014.08.025","article-title":"Novel roles for caspase-8 in IL-1\u03b2 and inflammasome regulation","volume":"185","author":"Gurung","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115817_bb0045","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/ard.2009.126573","article-title":"Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA","volume":"69","author":"Nam","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115817_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res."},{"key":"10.1016\/j.intimp.2025.115817_bb0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3389\/fphar.2020.00913","article-title":"Voltage-gated K(+)\/Na(+) channels and scorpion venom toxins in Cancer","volume":"11","author":"D\u00edaz-Garc\u00eda","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115817_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1152\/physiol.00010.2022","article-title":"Kv1. 3 K+ channel physiology assessed by genetic and pharmacological modulation","volume":"38","author":"Varanita","year":"2023","journal-title":"Physiology"},{"key":"10.1016\/j.intimp.2025.115817_bb0065","article-title":"Kv1. 3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases","volume":"28(9):3952","author":"Chhabra","year":"2014","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.intimp.2025.115817_bb0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ddr.20467","article-title":"The lymphocyte potassium channels Kv1. 3 and KCa3. 1 as targets for immunosuppression","volume":"72","author":"Lam","year":"2011","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115817_bb0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s12026-015-8683-8","article-title":"The effects of Kv1.3 and IKCa1 channel inhibition on cytokine production and calcium influx of T lymphocytes in rheumatoid arthritis and ankylosing spondylitis","volume":"64","author":"Toldi","year":"2016","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2025.115817_bb0080","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-1481-18","article-title":"Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression","volume":"25","author":"Oliveira","year":"2019","journal-title":"J Venom Anim Toxins Incl Trop Dis."},{"issue":"12","key":"10.1016\/j.intimp.2025.115817_bb0085","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.biochi.2010.08.003","article-title":"A potent potassium channel blocker from Mesobuthus eupeus scorpion venom","volume":"92","author":"Gao","year":"2010","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/j.intimp.2025.115817_bb0090","article-title":"Colombian Scorpion Centruroides margaritatus: Purification and Characterization of a Gamma Potassium Toxin with Full-Block Activity on the hERG1 Channel","volume":"13","author":"Beltr\u00e1n-Vidal","year":"2021","journal-title":"Toxins (Basel) [Internet]"},{"key":"10.1016\/j.intimp.2025.115817_bb0095","first-page":"1","article-title":"Genomic structure of two Kv1. 3 channel blockers from scorpion Mesobuthus eupeus and sea anemone Stichodactyla haddoni and construction of their chimeric peptide as a novel blocker","author":"Asadi","year":"2022","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.intimp.2025.115817_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106554","article-title":"Evaluation of encapsulated eugenol by chitosan nanoparticles on the aggressive model of rheumatoid arthritis","volume":"85","author":"Jabbari","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115817_bb0105","series-title":"Analysis of Cell Viability by the MTT Assay","volume":"vols. 2018(6):pdb-prot095505","author":"Kumar","year":"2018"},{"issue":"9","key":"10.1016\/j.intimp.2025.115817_bb0110","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3109\/13880209.2015.1125931","article-title":"Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats","volume":"54","author":"Wahba","year":"2016","journal-title":"Pharm. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115817_bb0115","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10787-022-00977-1","article-title":"Methotrexate-loaded biodegradable nanoparticles exert anti-arthritic effect by downregulating pro-inflammatory cytokines in Freund\u2019s complete adjuvant-induced arthritic rats","volume":"30","author":"Saleem","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2025.115817_bb0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/ph16010060","article-title":"Nano methotrexate versus methotrexate in targeting rheumatoid arthritis","volume":"16","author":"Salem","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.intimp.2025.115817_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/095632020701800303","article-title":"Anticytomegalovirus activity of pristimerin, a triterpenoid quinone methide isolated from Maytenus heterophylla (Eckl. & Zeyh.)","volume":"18","author":"Murayama","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"issue":"3","key":"10.1016\/j.intimp.2025.115817_bb0130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaut.2012.05.021","article-title":"Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction","volume":"39","author":"Boissier","year":"2012","journal-title":"J. Autoimmun."},{"issue":"2014","key":"10.1016\/j.intimp.2025.115817_bb0135","first-page":"698192","article-title":"Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis","volume":"21","author":"Niu","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115817_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041313","article-title":"Chitosan: a potential biopolymer in drug delivery and biomedical applications","volume":"15","author":"Desai","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.intimp.2025.115817_bb0145","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3390\/molecules23102661","article-title":"Chitosan-based nanomaterials for drug delivery","volume":"23","author":"Li","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2025.115817_bb0150","series-title":"Efek Anti Inflamasi Kitosan Dari Cangkang Udang Pantai Trisik Pada Tikus Model Rheumatoid Arthritis The Anti-Inflammatory Effects Of Chitosan Of Shrimp Shell Of Trisik Coastal In Rheumatoid Arthritic Rats Model","author":"Hanifah","year":"2025"},{"issue":"3","key":"10.1016\/j.intimp.2025.115817_bb0155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2174\/1567201820666230428124346","article-title":"Transdermal delivery of methotrexate loaded in chitosan nanoparticles to treat rheumatoid arthritis","volume":"21","author":"Al-Nemrawi","year":"2024","journal-title":"Curr. Drug Deliv."},{"issue":"5","key":"10.1016\/j.intimp.2025.115817_bb0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2174\/2211738511666230502154110","article-title":"Novel chitosan nanoparticles loaded with methotrexate for topical treatment of psoriasis","volume":"11","author":"Al-Nemrawi","year":"2023","journal-title":"Pharm Nanotechnol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115817_bb0165","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/iub.2248","article-title":"Antiarthritic effect of chitosan nanoparticle loaded with embelin against adjuvant-induced arthritis in Wistar rats","volume":"72","author":"Cui","year":"2020","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.intimp.2025.115817_bb0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.30595\/pharmacy.v19i1.13842","article-title":"Analgesic activity of chitosan in arthritis rats induced by complete Freund\u2019s adjuvant (CFA)","volume":"19","author":"Putri","year":"2022","journal-title":"Pharm J Farm Indones Pharmaceutical J Indones"},{"issue":"3","key":"10.1016\/j.intimp.2025.115817_bb0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/iji.12664","article-title":"The role of monocyte\/macrophage chemokines in pathogenesis of osteoarthritis: a review","volume":"51","author":"Luo","year":"2024","journal-title":"Int. J. Immunogenet."},{"issue":"Pt B","key":"10.1016\/j.intimp.2025.115817_bb0180","article-title":"MCP-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115817_bb0185","series-title":"Kv1.3: A Multifunctional Channel with Many Pathological Implications","first-page":"101","volume":"22","author":"Serrano-Albarr\u00e1s","year":"2018"},{"issue":"12","key":"10.1016\/j.intimp.2025.115817_bb0190","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nrd2983","article-title":"Voltage-gated potassium channels as therapeutic targets","volume":"8","author":"Wulff","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2025.115817_bb0195","article-title":"Structure of the voltage-gated potassium channel K(V)1.3: insights into the inactivated conformation and binding to therapeutic leads","volume":"17(1):2253104","author":"Chandy","year":"2023","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.intimp.2025.115817_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2017.03.014","article-title":"Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog","volume":"180","author":"Tanner","year":"2017","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115817_bb0205","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1110\/ps.8.12.2672","article-title":"Structural and functional consequences of the presence of a fourth disulfide bridge in the scorpion short toxins: solution structure of the potassium channel inhibitor HsTX1","volume":"8","author":"Savarin","year":"1999","journal-title":"Protein Sci."},{"key":"10.1016\/j.intimp.2025.115817_bb0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.toxicon.2014.05.002","article-title":"Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels","volume":"87","author":"Bartok","year":"2014","journal-title":"Toxicon"},{"issue":"5","key":"10.1016\/j.intimp.2025.115817_bb0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/187152811797200641","article-title":"Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases","volume":"10","author":"Beeton","year":"2011","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"1","key":"10.1016\/j.intimp.2025.115817_bb0220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/md13010529","article-title":"Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK","volume":"13","author":"Pennington","year":"2015","journal-title":"Mar. Drugs"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925018053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:28:14Z","timestamp":1768404494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925018053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"alternative-id":["S1567576925018053"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115817","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ameliorative effects of chitosan nanoparticles containing a scorpion-derived potassium channel inhibitory peptide (alpha-KTx 3.13) in a juvenile model of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115817"}}